Trump slaps 100% tariff on some pharmaceutical drugs via executive order
President Donald Trump answers questions after signing an executive order to limit mail-in voting in the Oval Office of the White House, March 31, 2026, in Washington. (Alex Wong/Getty Images)
(WASHINGTON) — President Donald Trump on Thursday slapped 100% tariffs on some pharmaceutical products, ramping up his effort to boost U.S. drug manufacturing.
The move, in the form of an executive order, targets patented drugs that lack a “most favored nations” pricing agreement with the U.S. Under such agreements, companies ensure the U.S. will pay the same amount that other wealthy countries pay for similar medications.
Companies face a reduced levy if they agree to bring production to the U.S. or enter into pricing deals with the administration, the executive order says.
If companies commit to bring their manufacturing to America, then the tariff on their products will drop to 20%, the order notes.
In the event such companies also enter into a most-favored-nation agreement with the Department of Health and Human Services, then they can avert tariffs entirely while in the process of building a U.S.-based plant, according to the executive order.
Large companies, the executive order says, will receive a 120-day phase-in period before the tariffs take effect.
The fresh round of tariffs will exclude drugs made in some countries that previously entered into trade agreements with the U.S., including Switzerland, Japan, South Korea and the 27-member European Union, according to the order.
Pharmaceutical products from those countries will face a 15% tariff based on the terms of trade agreements reached with the U.S, the order notes.
This is a developing story. Please check back for updates.
ABC News’ Mary Kekatos contributed to this report.
Mark Zuckerberg (R), CEO of Meta testifies before the Senate Judiciary Committee at the Dirksen Senate Office Building on January 31, 2024 in Washington, DC. (Anna Moneymaker/Getty Images)
(WASHINGTON) — Mark Zuckerberg took the stand on Wednesday in a landmark Los Angeles trial alleging that major social media platforms were intentionally designed to be addictive for children and teens.
The case, which began last Monday in Los Angeles County Superior Court, centers on claims against Meta — the parent company of Facebook and Instagram — and YouTube, which is owned by Google. Plaintiffs argue the companies knowingly built features that encouraged compulsive use among young users, contributing to long-term mental health harm.
The lawsuit was brought by a now-20-year-old woman identified as “Kaley” and her mother, who allege she was exposed to addictive design features as a child. Her lawyers claim she got hooked on social media apps starting as young as age 6. She says features like auto-scrolling got her addicted to the platforms — ultimately leading to anxiety, depression and body image issues.
In opening statements, the plaintiffs’ attorney Mark Lanier told the jury the case was “as easy as ABC,” which he said stood for “addicting the brains of children.”
The case is the first of more than 1,500 similar lawsuits nationwide to go before a jury, potentially setting a precedent for how tech companies are held liable for product design.
Zuckerberg has appeared before Congress multiple times to address concerns over youth safety and online harms, but Wednesday marks the first time he will testify before a jury on these claims.
Several parents of children who died by suicide or accidental harm linked to online trends are expected to attend the proceedings. Some previously watched Zuckerberg apologize during a 2024 Capitol Hill hearing, where he acknowledged families who said social media contributed to their children’s deaths.
The companies deny the allegations, arguing that mental health outcomes are shaped by a range of factors beyond social media use. They say they have implemented safeguards aimed at protecting young users, including parental controls and accounts designed specifically for teens.
In a statement to ABC News at the start of the trial, a Meta spokesperson said, “We strongly disagree with these allegations and are confident the evidence will show our longstanding commitment to supporting young people.”
Meta said that the company has made “meaningful changes” to its services, such as introducing accounts specifically for teenage users.
Zuckerberg’s appearance follows testimony last week from Instagram head Adam Mosseri, who disputed characterizing Instagram use as an “addiction,” while acknowledging what he described as “problematic use.”
Mosseri testified that there’s always a tradeoff between “safety and speech,” saying users don’t like it when they remove options from Instagram.
The Los Angeles trial is part of a broader wave of litigation targeting social media companies. Meta is also facing a separate child safety lawsuit in New Mexico, while lawsuits brought by school districts — modeled after tobacco litigation in the 1990s — are expected to head to trial later this year.
Social platforms Snapchat and TikTok were previously named in the lawsuit but reached settlements with the plaintiffs last month.
James Gorman, Chairman of The Walt Disney Company Board of Directors stands with newly named CEO of The Walt Disney Company, Josh D’Amaro, newly named President and Chief Creative Officer of The Walt Disney Company Dana Walden and current CEO of The Walt Disney Company, Robert A. Iger. (Disney)
(NEW YORK) — The Walt Disney Company announced on Tuesday that Josh D’Amaro will become the company’s next CEO in March, replacing current chief executive Bob Iger when he steps down from the role this year. Dana Walden will become the company’s president and chief creative officer.
D’Amaro, chair of Disney’s experiences unit, oversees a global network of theme parks and hotel resorts. He also leads the company’s cruise ships and consumer products, among other initiatives. D’Amaro formally takes over the CEO role on March 18 at Disney’s upcoming annual meeting.
“Josh D’Amaro is an exceptional leader and the right person to become our next CEO,” Iger said in a statement on Tuesday.
“He has an instinctive appreciation of the Disney brand, and a deep understanding of what resonates with our audiences, paired with the rigor and attention to detail required to deliver some of our most ambitious projects. His ability to combine creativity with operational excellence is exemplary and I am thrilled for Josh and the company,” Iger added.
D’Amaro, 54, joined the company in 1998.
Walden is set to become the company’s president and chief creative officer, Disney said. Walden previously served as the head of Disney’s entertainment media, news and content businesses, including its streaming service.
Iger began his current tenure as CEO in 2022, after previously serving in the role from 2005 to 2020. He also served as chairman over that period. After stepping aside in 2020, Iger served as executive chairman and chairman of the board until 2021.
In a letter to shareholders in January, Disney Board Chairman James Gorman described management succession planning as a “top priority” for the company’s board of directors, according to a securities filing.
“Oversight of the process is led by our dedicated Succession Planning Committee, and all directors have actively participated in a rigorous and ongoing evaluation of potential successor candidates, including direct engagement, performance assessment and consideration of leadership capabilities aligned with the Company’s long-term strategy,” Gorman added.
Kevin Warsh, former governor of the US Federal Reserve, during the International Monetary Fund (IMF) and World Bank Spring meetings on Friday, April 25, 2025. (Tierney L. Cross/Bloomberg via Getty Images)
(WASHINGTON) — President Donald Trump’s selection to chair the Federal Reserve, Kevin Warsh, will testify in a Senate confirmation hearing on Tuesday as his nomination faces bipartisan opposition centered on a federal criminal investigation into the central bank’s current leader.
The probe into Fed Chair Jerome Powell, which focuses on alleged false testimony to Congress about an office renovation, threatens to derail or delay Warsh’s nomination.
Powell, who was appointed by Trump in 2017, has rebuked the probe as a politically motivated effort to influence interest-rate policy.
Warsh, a former Fed official, will likely face scrutiny from some lawmakers eager for assurance that he will set interest rates based on economic conditions, even if it puts him out of step with Trump’s preference for low interest rates.
Sen. Thom Tillis, R-N.C., a potentially decisive vote on the committee, says he will not move to advance the nomination until the Department of Justice resolves its unprecedented investigation into Fed Chair Jerome Powell.
Powell’s term as Fed chair ends on May 15, but he said last month he would stay in the position until Warsh is confirmed. For his part, Trump told Fox Business last week he would fire Powell if the current Fed chair attempts to remain in office past the end of his term.
Sen. Elizabeth Warren, D-Mass., the top Democrat on the committee, voiced concern in a statement last week about what she considers Warsh’s perceived lack of independence, saying he may end up being “Donald Trump’s sock puppet.”
By contrast, Sen. Tim Scott, R-S.C., the chairman of the Senate Banking Committee, has dismissed such worries in a post on X last week.
Under Warsh, Scott said, the Fed will “be focused solely on strengthening the American economy.”
Warsh, who previously worked on Wall Street and in the George W. Bush administration, brings experience in finance and policymaking.
He is currently a fellow at a conservative think tank called the Hoover Institution, which is based at Stanford University. He also works as a partner at the Duquesne Family Office, an investment firm founded by billionaire and former hedge fund manager Stanley Druckenmiller.
In 2006, Bush appointed Warsh to serve on the Fed’s Board of Governors, a top policymaking body that helps set the level of interest rates, where he served until 2011. His tenure overlapped with the 2008 financial crisis, during which he helped manage the central bank’s response under then-Chair Ben Bernanke.
The nomination of Warsh arrives at a delicate moment for the Fed, as it grapples with a challenging combination of elevated inflation and sluggish hiring. An interest-rate hike could help ease inflation but risks a further cooldown of the labor market, while a rate cut may boost hiring but threatens higher inflation.
During his term as a Fed governor in the late 2000s and early 2010s, Warsh gained a reputation as an interest-rate “hawk,” meaning he generally preferred higher interest rates as a means of ensuring low and stable inflation.
In recent months, however, Warsh has voiced support for lower interest rates, rebuking the Fed’s concern about inflation risk posed by a flurry of new tariffs issued last year.
Those remarks came before the U.S.-Israeli war with Iran, however, which sent inflation soaring last month.
The rapid acceleration of price increases could complicate interest rate policy at the Fed, which may be reluctant to lower borrowing costs as inflation climbs.
